Fukunaga M, Endo Y, Ushigome S
Department of Pathology, Jikei University School of Medicine, Tokyo, Japan.
Cytometry. 1995 Jun 15;22(2):135-8. doi: 10.1002/cyto.990220209.
In order to evaluate the significance of cytometric aneuploidy in molar placentas, we analyzed 197 hydatidiform moles by flow cytometry using formalin-fixed, paraffin-embedded tissues. Of 150 complete moles (CMs), 110 were diploid, 26 were tetraploid, and 14 were aneuploid (non-triploid/tetraploid aneuploid). Of 47 partial moles (PMs), 44 were triploid and 3 were diploid. We could not find any histologic differences among the diploid, tetraploid, and aneuploid CMs. We found that flow cytometric DNA analysis was very helpful to differentiate CM from PM. Persistent diseases developed in 12 of 69 CMs (17.4%) (9 of 47 diploid and 3 of 14 tetraploid CMs) and in none of 26 PMs (0%). Four diploid and 2 tetraploid CMs were invasive and one each with diploid and tetraploid CM developed choriocarcinoma and none of 8 aneuploid CMs had sequelae; however, there was no correlation between DNA ploidy and clinical outcome in the CMs. These results suggest that cytometric aneuploidy (non-diploidy) in CMs is not an independent predictor of persistent disease.
为了评估细胞计量学非整倍体在葡萄胎胎盘组织中的意义,我们使用福尔马林固定、石蜡包埋的组织,通过流式细胞术分析了197例葡萄胎。在150例完全性葡萄胎(CM)中,110例为二倍体,26例为四倍体,14例为非整倍体(非三倍体/四倍体非整倍体)。在47例部分性葡萄胎(PM)中,44例为三倍体,3例为二倍体。我们未发现二倍体、四倍体和非整倍体CM之间存在任何组织学差异。我们发现流式细胞术DNA分析对于区分CM和PM非常有帮助。69例CM中有12例(17.4%)出现持续性疾病(47例二倍体CM中有9例,14例四倍体CM中有3例),而26例PM中无一例(0%)出现持续性疾病。4例二倍体CM和2例四倍体CM具有侵袭性,各有1例二倍体和四倍体CM发展为绒毛膜癌,8例非整倍体CM均无后遗症;然而,CM中的DNA倍性与临床结局之间无相关性。这些结果表明,CM中的细胞计量学非整倍体(非二倍体)不是持续性疾病的独立预测指标。